Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Curcumin × Clear all

NCT04731844 2024-07-12

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Phase 2 Recruiting

GenitourinaryPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Prostatic Neoplasms

NCT02724618 2017-10-12

Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)

Phase 2 Unknown

Prostatic Neoplasms